pyrophosphate and Esophageal-Neoplasms

pyrophosphate has been researched along with Esophageal-Neoplasms* in 2 studies

Other Studies

2 other study(ies) available for pyrophosphate and Esophageal-Neoplasms

ArticleYear
Phospholysine phosphohistidine inorganic pyrophosphate phosphatase suppresses human esophageal cancer cell growth by inducing mitotic catastrophe through the P27/cyclin A/CDK2 signaling pathway.
    Acta histochemica, 2023, Volume: 125, Issue:6

    Esophageal cancer (ESCA) is a global dead malignancy with poor prognosis. However, its underlying molecular mechanism remains to be elucidated. Phospholysine phosphohistidine inorganic pyrophosphate phosphatase (LHPP) has been reported as a tumor suppressor in multisystem cancer but its function in ESCA has not been reported. We analyzed LHPP expression between normal and tumor tissues of ESCA patients and performed LHPP overexpression on the ESCA cells KYSE-150 (K150). We did not observe significant differences in the expression level of LHPP between ESCA and normal tissue, and noticed that LHPP expression was not related to ESCA patient survival rate. However, increased expression of LHPP in K150 cells induced mitochondrial dysfunction, inhibited cell proliferation, migration, and cell cycle, and simultaneously increased cell apoptosis. Besides, we found that K150 cells underwent mitotic catastrophe after overexpressing LHPP, which may be regulated through the P27/cyclin A/cdk2 signaling pathway. Although the expression of LHPP may not be related to the progression and prognosis of ESCA, mitotic catastrophe, a new mechanism of tumor suppressor function of LHPP was found after overexpressing LHPP in ESCA cells. DATA AVAILABILITY: The data used to support the findings of this study are included within the article.

    Topics: Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase 2; Diphosphates; Esophageal Neoplasms; Humans; Phosphoric Monoester Hydrolases; Signal Transduction

2023
Bone tumor imaging by scintigraphy of the skeleton, marrow reticuloendothelial system, and the proliferative tissue.
    The American journal of roentgenology, radium therapy, and nuclear medicine, 1975, Volume: 125, Issue:4

    Paralleled clinical studies of radioisotopic imaging or tumor metastases in the bone were undertaken with Tc99m pyrophosphate, Ga67 citrate, and Tc99m sulfur colloid. All three were capable of anticipating the bone roentgenograms. A critical analysis suggested that positive delineation with Ga67 citrate would sometimes be superior to the others. This deserves further investigation. Clinically the combined use of Tc99m pyrophosphate with Ga67 for the chest areas and extremties or with Tc99m colloid for the pelvic and abdominal areas would be more frutiful in early detection and exact localization of bone metastases.

    Topics: Bone Neoplasms; Breast Neoplasms; Carcinoma, Squamous Cell; Citrates; Colloids; Diagnosis, Differential; Diphosphates; Esophageal Neoplasms; Humans; Leiomyosarcoma; Neoplasm Metastasis; Pancreatic Neoplasms; Radionuclide Imaging; Technetium

1975